Historical record - last NADAC publication: 2/21/2024
Product Information
FENOFIBRATE 134 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.1089 per EA under NDC 69097089507. Its NADAC has been published 354 times since May 17, 2017.
Strength
134 mg/1
Manufacturer
Cipla USA Inc.NDC
69097089507
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/21/2024
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207378On Market Since
3/30/2017
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 134 MG CAPSULE has been published 354 times since May 17, 2017, and over the history we have for it it has declined 89.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1089 per EA |
|---|---|
| All-time high | $1.0421 (Aug 16, 2017) |
| All-time low | $0.1089 (Feb 21, 2024) |
| Median price | $0.2771 |
| Average price | $0.3544 |
| Largest weekly change | +38.9% (Sep 23, 2020) |
| Weeks tracked | 354 |
| Tracking since | May 17, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 134 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 134 MG CAPSULE, manufactured by Cipla USA Inc., is $0.1089 per EA (NDC 69097089507), effective Feb 21, 2024.
How has the price of FENOFIBRATE 134 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 134 MG CAPSULE has declined 89.2%. It has been tracked across 354 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 134 MG CAPSULE?
Since May 17, 2017, the NADAC for FENOFIBRATE 134 MG CAPSULE has ranged from a low of $0.1089 (Feb 21, 2024) to a high of $1.0421 (Aug 16, 2017), with a median of $0.2771 per EA.
Are there cheaper alternatives to FENOFIBRATE 134 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as FENOFIBRATE 134 MG CAPSULE, but none are currently priced below it.
Who manufactures FENOFIBRATE 134 MG CAPSULE?
FENOFIBRATE 134 MG CAPSULE (NDC 69097089507) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification